These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26370008)

  • 1. Low Serum Levels of Interleukin 35 in Patients with Rheumatoid Arthritis.
    Ning X; Jian Z; Wang W
    Tohoku J Exp Med; 2015 Oct; 237(2):77-82. PubMed ID: 26370008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies.
    Chang QJ; Lv C; Zhao F; Xu TS; Li P
    Tohoku J Exp Med; 2017 Feb; 241(2):89-95. PubMed ID: 28154345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
    Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
    Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
    Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
    J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
    El-Banna H; Jiman-Fatani A
    BMC Musculoskelet Disord; 2014 Nov; 15():379. PubMed ID: 25406539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
    Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
    Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
    Yang CL; Zhou YR; Zhou F; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
    de Siqueira MB; da Mota LM; Couto SC; Muniz-Junqueira MI
    BMC Musculoskelet Disord; 2015 Jun; 16():159. PubMed ID: 26123215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
    Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S
    Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
    Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
    Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.
    Moon SJ; Hong YS; Ju JH; Kwok SK; Park SH; Min JK
    J Rheumatol; 2013 Nov; 40(11):1842-9. PubMed ID: 23996288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
    Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
    Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.